Net Income Veränderung Datum
Agios Pharmaceuticals USD -95940000 4.62M 2023-12
Almirall EUR 12.01M 35.07M 2023-06
Amarin USD -19311000 1.75M 2023-09
Amgen USD 767M 963M 2023-12
Artemis Alpha GBP -16638000 10.13M 2022-06
AstraZeneca USD 1.37B 444M 2023-09
Bayer EUR -4569000000 2.68B 2023-09
BioMarin Pharmaceutical USD 20.38M 20M 2023-12
Bluebird Bio USD -71731000 1.18M 2023-09
Demant DKK 581M 452M 2023-06
Exelixis USD 1.04M 80.14M 2023-09
Fresenius Medical Care EUR 84M 56M 2023-09
Galapagos EUR 25.83M 20.73M 2023-09
Genmab DKK 2.13B 772M 2023-09
GlaxoSmithKline GBP 1.46B 160M 2023-09
GN Store Nord DKK 213M 181M 2023-09
GRIFOLS EUR 55.99M 3.55M 2023-12
Hikma Pharmaceutical USD 131M 116M 2023-06
Insmed USD -186061000 27.13M 2023-12
Lonza CHF 410M 313M 2023-06
Merck EUR 738M 35M 2023-09
Novartis USD 1.76B 553M 2023-09
Regeneron Pharmaceuticals USD 1.16B 151.8M 2023-12
Roche Holding CHF 7.14B 3.25B 2023-06
UCB EUR 311M 292M 2023-06



Genmab Nettoeinkommen - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Mar 2024.